½ÃÀ庸°í¼­
»óǰÄÚµå
1372461

¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå - À¯Çü, Á¦°ø ÇüÅÂ, ¿ëµµ ¹× ÃÖÁ¾ ¿ëµµº°, ¿¹Ãø(2023-2032³â)

Surgical Planning Software Market - By Type (Pre-operative, Post-operative), Mode of Delivery (Cloud-based, On-premise), Application (Orthopedic, Neurosurgery, Dental & Orthodontics), End-use & Forecast, 2023-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 190 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº 2023³âºÎÅÍ 2032³â±îÁö 6.1%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¾÷°è ´ë±â¾÷ÀÇ ±â¼ú Çõ½Å°ú »õ·Î¿î ¼ö¼ú ¼ÒÇÁÆ®¿þ¾î ÇÁ·Î±×·¥ µµÀÔÀÌ Áõ°¡Çϸ鼭 ½ÃÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 10¿ù ¹Ì±¹ ¾È°ú ÀÇ·á ±â¾÷ º¸½´·ÒÀº ¾ÆÀÌ ÀÎÅÚ¸®Àü½º Ç÷§ÆûÀÇ ÀϺηΠ»õ·Î¿î ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ¼ÒÇÁÆ®¿þ¾î´Â ¼ö¼ú °èȹ ¹× Á¤º¸ °ü¸®¸¦ ÃÖÀûÈ­Çϰí ÀüÀÚ ÀÇ·á ±â·Ï ¹× Áø´Ü Àåºñ¿ÍÀÇ ¿øÈ°ÇÑ ÅëÇÕÀ» ÃËÁøÇÏ´Â µ¿½Ã¿¡ ¼ö¼ú °èȹ ¹× Á¤º¸ °ü¸®¸¦ ÃÖÀûÈ­Çϵµ·Ï ¸¸µé¾îÁ³½À´Ï´Ù.

¼±±¸ÀûÀÎ ±â¾÷µéÀº ¼ö¼ú °èȹ, Á¤È®¼º ¹× °á°ú¸¦ Çâ»ó½ÃŰ´Â ÃÖ÷´Ü µµ±¸¸¦ Áö¼ÓÀûÀ¸·Î °³¹ßÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀº ÀýÂ÷¸¦ °£¼ÒÈ­ ÇÒ»Ó¸¸ ¾Æ´Ï¶ó ÃÖ¼Ò Ä§½À ¼ö¼ú ¹× °³ÀÎÈ­ µÈ Ä¡·á °èȹÀÇ °¡´É¼ºÀ» È®´ëÇÏ¿© ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¼ö¼ú ÈÄ ºÎ¹®Àº 2023³âºÎÅÍ 2032³â±îÁö Å« ¹ßÀüÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¼ÒÇÁÆ®¿þ¾î´Â ȯÀÚÀÇ È¸º¹À» ¸ð´ÏÅ͸µÇÏ°í °ü¸®ÇÏ´Â µ¥ µµ¿òÀ» ÁÜÀ¸·Î½á ¼ö¼ú ÈÄ ´Ü°è¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÇ·á Àü¹®°¡°¡ ¼ö¼ú °á°ú¸¦ ÃßÀûÇϰí ÇÕº´ÁõÀ» Æò°¡ÇÏ°í ±×¿¡ µû¶ó Ä¡·á °èȹÀ» Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á »ê¾÷¿¡¼­ ¼ö¼ú ÈÄ °ü¸®¿Í ȯÀÚ °á°ú °³¼±¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ ºÐ¾ßÀÇ ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀº °è¼Ó Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

½Å°æ¿Ü°ú ºÐ¾ß´Â 2023³âºÎÅÍ 2032³â±îÁö ÁÖ¸ñÇÒ ¸¸ÇÑ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ½Å°æ¿Ü°ú ¼ö¼úÀº º¹ÀâÇÏ°í ¼¶¼¼Çϱ⠶§¹®¿¡ Á¤È®ÇÑ °èȹ°ú ½ÇÇàÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î´Â ½Å°æ¿Ü°ú Àǻ翡°Ô ³ú ±¸Á¶ ¸ÅÇÎ, ½Ã¼ú ½Ã¹Ä·¹À̼Ç, ȯÀÚº° Ä¡·á °èȹÀ» °­È­ÇÒ ¼ö ÀÖ´Â °í±Þ µµ±¸¸¦ Á¦°øÇÕ´Ï´Ù. ½Å°æ¿Ü°ú ¼ö¼úÀÇ Á¤È®¼º°ú ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ ºÐ¾ß¿¡¼­ ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå Àü¸ÁÀÇ ±â¿©°¡ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù.

MEAÀÇ ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº 2023³âºÎÅÍ 2032³â±îÁö ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, MEAÀÇ ÀÇ·á ºÎ¹®ÀÌ ¹ßÀüÇϰí ÷´Ü ÀÇ·á ±â¼ú¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î´Â ¼ö¼úÀÇ Á¤È®¼º°ú ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϸ鼭 ÁÖ¸ñÀ» ¹Þ°í ÀÖÀ¸¸ç, MEAÀÇ ÀÇ·á ½Ã¼³ÀÌ ´õ ³ªÀº ȯÀÚ Ä¡·á¿Í Çâ»óµÈ ¼ö¼ú ÀýÂ÷¸¦ À§ÇØ ³ë·ÂÇϰí Àֱ⠶§¹®¿¡ ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î¿¡ ´ëÇÑ ¼ö¿ä´Â ÀÌ Áö¿ª¿¡¼­ Áõ°¡ÇÏ´Â Ãß¼¼ÀÔ´Ï´Ù.

¿¹¸¦ µé¾î, 2023³â 10¿ù À̽º¶ó¿¤ÀÇ VUZE MedicalÀº ÃÖ¼Ò Ä§½À ôÃß ¼ö¼úÀÇ ¼ö¼ú Áß °¡À̵带 Çõ½ÅÇÏ´Â µ¥ ÁÖ·ÂÇÏ´Â ºñ»óÀå ±â¾÷ VUZE MedicalÀº ¹Ì±¹ ½ÄǰÀǾ౹(FDA)¿¡ 2¼¼´ë VUZE ½Ã½ºÅÛ 'VUZE 2.0'¿¡ ´ëÇÑ 510(k) ½Åû¼­¸¦ Á¦ÃâÇß½À´Ï´Ù. MedicalÀº NASS 2023¿¡¼­ ÀÌ Â÷¼¼´ë ôÃß ¼ö¼ú¿ë ¼ÒÇÁÆ®¿þ¾î ±â¹Ý ¾È³» ½Ã½ºÅÛÀ» ¹ßÇ¥ÇÒ ¿¹Á¤ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ¾÷°è ÀλçÀÌÆ®

  • ¾÷°è »óȲ
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÃÖ¼Òħ½À ¼ö¼ú°ú ¸ÂÃãÇü Ä¡·á Àü·«¿¡ ´ëÇÑ ±âÈ£ »ó½Â
      • ¿µ»ó ±â¼ú Áøº¸
      • Á¤Çü¿Ü°ú ¼ö¼ú°ú µÎ°³ ¼ö¼ú Áõ°¡
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©¿Í °úÁ¦
      • ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾îÀÇ µµÀÔ°ú À¯Áö¿¡ µû¸¥ °íºñ¿ë
      • Áö¿ª¿¡ µû¶ó ÷´Ü ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ÇÑÁ¤Àû
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • COVID-19 ¿µÇ⠺м®
  • ±ÔÁ¦ »óȲ
  • ±â¼ú »óȲ
  • Porters ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï »óȲ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • ±â¾÷ Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : À¯Çüº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : À¯Çüº°
  • ¼ö¼úÀü
  • ¼ö¼úÈÄ

Á¦6Àå ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Á¦°ø Çüź°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : Á¦°ø Çüź°
  • Ŭ¶ó¿ìµå ±â¹Ý
  • ¿ÂÇÁ·¹¹Ì½º

Á¦7Àå ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¿ëµµº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : ¿ëµµº°
  • Á¤Çü¿Ü°ú
  • ½Å°æ¿Ü°ú
  • Ä¡°ú ¹× ±³Á¤Ä¡°ú
  • ±âŸ ¿ëµµ

Á¦8Àå ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : ÃÖÁ¾ ¿ëµµº°
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC)

Á¦9Àå ¼ö¼ú °èȹ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Áö¿ªº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ : Áö¿ªº°
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ±âŸ MEA

Á¦10Àå ±â¾÷ °³¿ä

  • Stryker
  • Zimmer Biomet.
  • Medtronic
  • Materialise
  • Brainlab AG
  • 3D Systems Inc.
  • mediCAD Hectec GmbH
  • DePuy Synthes(Johnson & Johnson Medical Devices Companies)
  • CANON MEDICAL SYSTEMS USA, INC.
  • General Electric Company
  • Renishaw Plc.
ksm 23.11.15

Global Surgical Planning Software Market will witness 6.1% CAGR between 2023 and 2032. The increasing innovation and introduction of new surgical software programs by industry leaders support the market. For instance, in October 2023, Bausch + Lomb, an American eye health company, unveiled novel surgical planning software as part of the Eyetelligence platform. This software is crafted to optimize surgical planning and information management while facilitating seamless integration with electronic medical records and diagnostic devices, as detailed in an official press statement.

Leading companies are continually developing cutting-edge tools that enhance surgical planning, precision, and outcomes. These innovative solutions not only streamline procedures but also expand the possibilities of minimally invasive surgeries and personalized treatment plans, thus driving the surgical planning software market demand.

The overall Surgical Planning Software Market is classified based on type, applications, and region.

Post-operative segment will undergo significant development from 2023 to 2032. This software plays a vital role in the post-operative phase by aiding in monitoring and managing patient recovery. It allows healthcare professionals to track surgical outcomes, assess complications, and adapt treatment plans accordingly. As the healthcare industry emphasizes improved post-operative care and patient outcomes, the surgical planning software market growth in this context will continue to rise.

Neurosurgery segment will register a notable CAGR from 2023 to 2032. With its intricate and delicate procedures, neurosurgery requires precise planning and execution. Surgical planning software provides neurosurgeons with advanced tools for mapping brain structures, simulating procedures, and enhancing patient-specific treatment plans. As the demand for neurosurgical precision and patient safety increases, the contribution of surgical planning software market outlook is becoming increasingly vital in the field.

MEA surgical planning software market will showcase an appreciable CAGR from 2023 to 2032. The healthcare sector in MEA is evolving and investing in advanced medical technologies. Surgical planning software is gaining prominence for its role in improving surgical precision and patient outcomes. As healthcare facilities in MEA strive for better patient care and enhanced surgical procedures, the demand for surgical planning software is on the upswing in the region.

For instance, in October 2023, VUZE Medical, Israel, a privately owned company focused on revolutionizing intra-operative guidance for minimally invasive spinal procedures, filed a 510(k) submission with the U.S. Food and Drug Administration (FDA) for its second-generation VUZE System, VUZE 2.0. VUZE Medical will be Presenting this next-generation software-based guidance system for spine surgery at NASS 2023.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition & scope
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Global surgical planning software industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Type trends
    • 2.1.4 Mode of delivery trends
    • 2.1.5 Application trends
    • 2.1.6 End-use trends

Chapter 3 Surgical Planning Software Industry Insights

  • 3.1 Industry landscape
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing preference for minimally invasive surgeries and personalized treatment strategies
      • 3.2.1.2 Technological advancements in imaging technology
      • 3.2.1.3 Rise of orthopedic and cranial procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High costs associated with implementing and maintaining surgical planning software
      • 3.2.2.2 Limited access to advanced technologies in certain regions
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By mode of delivery
    • 3.3.3 By application
    • 3.3.4 By end-use
  • 3.4 COVID- 19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Technology landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Competitive analysis of major market players, 2022
  • 4.4 Company positioning matrix, 2022
  • 4.5 Strategy dashboard, 2022

Chapter 5 Surgical Planning Software Market, By Type, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by type
  • 5.2 Pre-operative
  • 5.3 Post-operative

Chapter 6 Surgical Planning Software Market, By Mode of Delivery, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by mode of delivery
  • 6.2 Cloud-based
  • 6.3 On-premise

Chapter 7 Surgical Planning Software Market, By Application, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by application
  • 7.2 Orthopedic surgery
  • 7.3 Neurosurgery
  • 7.4 Dental and orthodontics
  • 7.5 Other applications

Chapter 8 Surgical Planning Software Market, By End-use, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by end-use
  • 8.2 Hospitals
  • 8.3 Specialty clinics
  • 8.4 Ambulatory Surgical Centers (ASCs)

Chapter 9 Surgical Planning Software Market, By Region, 2018 - 2032 (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 MEA
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of MEA

Chapter 10 Company Profiles

  • 10.1 Stryker
  • 10.2 Zimmer Biomet.
  • 10.3 Medtronic
  • 10.4 Materialise
  • 10.5 Brainlab AG
  • 10.6 3D Systems Inc.
  • 10.7 mediCAD Hectec GmbH
  • 10.8 DePuy Synthes (Johnson & Johnson Medical Devices Companies)
  • 10.9 CANON MEDICAL SYSTEMS USA, INC.
  • 10.10 General Electric Company
  • 10.11 Renishaw Plc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦